臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yeh k h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 516-540 / 753 (共31頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-04-10T12:51:12Z	Erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)	Chiun Hsu; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:51:12Z	Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients	Chen I.C.; Chiun Hsu; Chen Y.C.; Chien S.F.; Kao H.F.; Chang S.Y.; Hu F.C.; Yeh K.H.
臺大學術典藏	2020-04-10T12:51:10Z	Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer	Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:09Z	Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers	Kao H.-F.;Chen I.-C.;Chiun Hsu;Chang S.-Y.;Chien S.-F.;Chen Y.-C.;Hu F.-C.;Yang J.C.-H.;Cheng A.-L.;Yeh K.-H.; Kao H.-F.; Chen I.-C.; Chiun Hsu; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:51:07Z	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity	Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Chiun Hsu; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:03Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Chiun Hsu;Hsu C.-H.;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Chiun Hsu; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2020-04-10T12:50:58Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	Yang S.-H.;Guo J.-C.;Chiun Hsu;Kuo S.-H.;Tien Y.-W.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Guo J.-C.; Chiun Hsu; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:16:10Z	Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer	Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Hsu C.; Cheng W.-F.; Hsu C.-H.; YU-YUN SHAO; Lu L.-C.
臺大學術典藏	2020-04-10T12:16:07Z	Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer	Chen K.-H.;Yu-Yun Shao;Lin Z.-Z.;Yeh Y.-C.;Wen-Yi S.;Kuo R.N.;Chen H.-M.;Lai C.-L.;Yeh K.-H.;Cheng A.-L.;Lai M.-S.; Chen K.-H.; YU-YUN SHAO; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; Yeh K.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2020-04-10T12:16:04Z	Young patients with colorectal cancer have increased risk of second primary cancers	Liang Y.-H.;Yu-Yun Shao;Chen H.-M.;Lai C.-L.;Lin Z.-Z.;Kuo R.N.;Cheng A.-L.;Yeh K.-H.;Lai M.-S.; Liang Y.-H.; YU-YUN SHAO; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; Yeh K.-H.; Lai M.-S.
臺大學術典藏	2020-04-10T12:16:02Z	Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan	Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.; Yu-Yun Shao;Hsu C.-H.;Yeh K.-H.;Chen H.-M.;Yeh Y.-C.;Lai C.-L.;Lin Z.-Z.;Cheng A.-L.;Lai M.-S.; YU-YUN SHAO; Hsu C.-H.; Yeh K.-H.; Chen H.-M.
臺大學術典藏	2020-04-10T12:16:00Z	Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study	Liang Y.-H.;Yu-Yun Shao;Chen H.-M.;Cheng A.-L.;Lai M.-S.;Yeh K.-H.; Liang Y.-H.; YU-YUN SHAO; Chen H.-M.; Cheng A.-L.; Lai M.-S.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:15:59Z	Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer	Liang Y.-H.;Wei C.-H.;Hsu W.-H.;Yu-Yun Shao;Lin Y.-C.;Chou P.-C.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Wei C.-H.; Hsu W.-H.; YU-YUN SHAO; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-04-09T09:43:08Z	Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer	Wei, C. H.; Liang, Y. H.; Hsu, W. H.; Shao, Y. Y.; Lin, Y. C.; Chou, P. C.; Cheng, A. L.; Yeh, K. H.
臺大學術典藏	2020-03-31T03:59:24Z	Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma	Hsu C.-H.; Yeh K.-H.; Cheng A.-L.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; JANG-MING LEE; Huang P.-M.; Chang C.-H.; Lin C.-C.; Hsieh M.-S.; Guo J.-C.; Huang T.-C.
臺大學術典藏	2020-03-31T03:59:16Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Jang-Ming Lee; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; JANG-MING LEE
臺大學術典藏	2020-03-31T03:59:14Z	Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma	Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; JANG-MING LEE; Wang H.-P.; Chia-Hsien Cheng J.; Wu Y.-C.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Jang-Ming Lee;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.
臺大學術典藏	2020-03-23T07:19:32Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Hsu C.; Yeh K.-H.; Wu C.-Y.; CHIUN-SHENG HUANG; Yang C.-H.; Lu Y.-S.; Hsu C.-H.; Cheng A.-L.; Lin C.-C.
臺大學術典藏	2020-03-23T07:19:26Z	Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation	Lin P.-H.;Lu Y.-S.;Lin C.-H.;Chang D.-Y.;Chiun-Sheng Huang;Cheng A.-L.;Yeh K.-H.; Lin P.-H.; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; CHIUN-SHENG HUANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-23T04:00:49Z	Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer	Wu M.-S.; Shun C.-T.; Lin J.-T.; Cheng A.-L.; Wang H.-P.; MING-TSAN LIN; Yeh K.-H.; Lai I.-R.; Kuo S.-H.; Chen C.-C.; Tsai K.-F.;Liou J.-M.;Chen M.-J.;Chen C.-C.;Kuo S.-H.;Lai I.-R.;Yeh K.-H.;Ming-Tsan Lin;Wang H.-P.;Cheng A.-L.;Lin J.-T.;Shun C.-T.;Wu M.-S.; Tsai K.-F.; Liou J.-M.; Chen M.-J.
臺大學術典藏	2020-03-07T06:57:16Z	Nasal septal tumor as a sole presentation in the head and neck region in Rosai-Dorfman disease	Ko J.-Y.; Wu C.-T.; Yeh K.-H.; YIH-LEONG CHANG; Sheen T.-S.; Sheen T.-S.;Yih-Leong Chang;Yeh K.-H.;Wu C.-T.;Ko J.-Y.
臺大學術典藏	2020-03-07T06:56:33Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-07T06:56:33Z	KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:25Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:23Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.

顯示項目 516-540 / 753 (共31頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52891780 線上人數 : 766 教育部委託研究計畫計畫執行:國立臺灣大學圖書館